BaseSpace
Correlation
Engine-Public
Sign In
Register
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
rs4950928
,
CYP51
,
Metabolism of xenobiotics
,
Lung cancer
,
Heart
,
Avian flu virus
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
CD112
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
Cerebellar hemisphere
Transverse colon
Ascending colon
Cerebellar vermis
Sigmoid colon
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Diarrhea
Sepsis due to Serratia
Stricture of artery
Placental insufficiency
Tuberculosis
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
Rolipram
Chlorprothixene
Diethylcarbamazine
Benperidol
Cefoxitin
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
Stat3
MIR429
ULK2
ULK1
OXA1L
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Loading...
Explore Curated Studies Results
Literature
Most Relevant Literature
CD112 Supports Lymphatic Migration of Human Dermal Dendritic Cells.
CD112 is an epithelial-to-mesenchymal transition-related and immunological biomarker in pan-cancer.
PVRL2 Suppresses Antitumor Immunity through PVRIG- and TIGIT-independent Pathways.
Extracellular CIRP Induces Novel Nectin-2+ (CD112+) Neutrophils to Promote Th1 Differentiation in Se…
Nectin-2 in general and in the brain.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
A Phase I Clinical Study of HLX53 in Advanced/Metastatic Solid Tumors or Lymphoma
A Phase Ia/Ib Open Label,Clinical Study Evaluating the Safety, Tolerability and Preliminary Efficacy…
Immune Cells as a New Biomarker of Response in Patients Treated by Immunotherapy for Advanced Hepato…
Study to Evaluate Safety and PK of CHS-006 in Combination With Toripalimab in Patients With Advanced…
Cadonilimab in Patients (Pts) with Advanced Non-small Cell Lung Cancer (NSCLC)
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ